Polyomavirus neutralizing antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9862760
SERIAL NO

15258925

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGBASEL SUI BASEL BASEL-STADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abend, Johanna Emeryville, US 10 37
Dragic, Zorica Basel, CH 10 34
Feire, Adam Lloyd Hull, US 10 37
Knapp, Mark Oakland, US 46 539
Kovacs, Steven Randolph, US 9 34
Traggiai, Elisabetta Basel, CH 14 38
Wang, Lichun Shanghai, CN 65 130
Wang, Yongqiang Shanghai, CN 146 785
Wu, Danqing Shanghai, CN 11 35
Wu, Qilong Shanghai, CN 43 953
Xu, Fangmin Belmont, US 33 680

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 9, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 9, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00